» Articles » PMID: 2263221

Hormone Replacement Therapy: Use Patterns in 51-year-old Danish Women

Overview
Journal Maturitas
Specialty Geriatrics
Date 1990 Nov 1
PMID 2263221
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

A survey based on a postal questionnaire sent to all women born in 1936 living in four Copenhagen suburbs (n = 597, response rate = 88%) revealed an overall prevalence of hormone replacement therapy (HRT) use of 22% and a cumulative incidence of 37%. This paper describes the use of HRT in this population and the patterns of exposure to treatment. Our results indicate that the use of HRT, particularly combined oestrogen-progestogen therapy, is increasing and is being initiated during the pre-menopause. Climacteric complaints were the main reason for starting treatment; only a minority of the respondents were motivated by prophylactic considerations. Forty percent discontinued treatment, the majority stating that they had done so because of unpleasant adverse reactions or lack of effect.

Citing Articles

Levetiracetam for the treatment of hot flashes: a phase II study.

Thompson S, Bardia A, Tan A, Barton D, Kottschade L, Sloan J Support Care Cancer. 2007; 16(1):75-82.

PMID: 17598133 DOI: 10.1007/s00520-007-0276-1.


Performance of four clinical screening tools to select peri- and early postmenopausal women for dual X-ray absorptiometry.

Rud B, Jensen J, Mosekilde L, Nielsen S, Hilden J, Abrahamsen B Osteoporos Int. 2005; 16(7):764-72.

PMID: 15986263 DOI: 10.1007/s00198-004-1748-5.


Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark.

Vestergaard P, Rejnmark L, Mosekilde L Osteoporos Int. 2004; 16(2):134-41.

PMID: 15197546 DOI: 10.1007/s00198-004-1680-8.


Hot flashes: aetiology and management.

Barton D, Loprinzi C, Wahner-Roedler D Drugs Aging. 2001; 18(8):597-606.

PMID: 11587246 DOI: 10.2165/00002512-200118080-00004.


Factors determining the use of hormone replacement therapy in recent naturally postmenopausal women participating in the French SU.VI.MAX cohort.

Briancon S, Potier de Courcy G, Preziosi P, Fieux B, Zarebska M, Galan P Eur J Epidemiol. 2000; 16(5):477-82.

PMID: 10997836 DOI: 10.1023/a:1007616029063.